Daily close, T-120 (9/2/25) through T+5. Run-up high $22.7 on 2/16/26, low $16.67 on 10/21/25 (T-120 to T-1). FDA decision 2/17/26. Historical price action, not a forecast.
Yes. The FDA approved the application for primary-sourced on February 17, 2026. The primary source is linked on this page.
How did INVA stock react to the FDA decision?
On the decision day INVA moved +5.1%. That is the recorded reaction to this specific event -- historical measurement, not a prediction, and not investment advice.